Vimarsana
Biggest News Aggregation in the World

Ellen Chiniara News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ellen Chiniara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ellen Chiniara Today - Breaking & Trending Today

Compass Therapeutics : 2024 Proxy Supplemental - Vimarsana News

Compass Therapeutics : 2024 Proxy Supplemental

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy...

Stifel Nicolaus Raises Kymera Therapeutics (NASDAQ:KYMR) Price Target to $55.00 - Vimarsana News

Stifel Nicolaus Raises Kymera Therapeutics (NASDAQ:KYMR) Price Target to $55.00

Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) had its price objective upped by Stifel Nicolaus from $35.00 to $55.00 in a report released on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 35.84% from the stock’s previous close. Other research analysts […]

Kymera Therapeutics (NASDAQ:KYMR) Trading Down 1.9% After Insider Selling - Vimarsana News

Kymera Therapeutics (NASDAQ:KYMR) Trading Down 1.9% After Insider Selling

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) traded down 1.9% during trading on Monday following insider selling activity. The stock traded as low as $36.22 and last traded at $36.49. 178,419 shares changed hands during trading, a decline of 80% from the average session volume of 883,645 shares. The stock had previously closed at […]

Leerink Partnrs Weighs in on Kymera Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:KYMR) - Vimarsana News

Leerink Partnrs Weighs in on Kymera Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:KYMR)

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Analysts at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of Kymera Therapeutics in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($0.79) per share for the quarter. Leerink Partnrs currently has […]

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2022 Earnings Call Transcript - Vimarsana News

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2022 Earnings Call Transcript

Operator: Hello, and welcome to the Kymera Therapeutics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.